ATE550323T1 - Piperidinyl-prostaglandinanaloga als den augeninnendruck senkende mittel - Google Patents

Piperidinyl-prostaglandinanaloga als den augeninnendruck senkende mittel

Info

Publication number
ATE550323T1
ATE550323T1 AT05749871T AT05749871T ATE550323T1 AT E550323 T1 ATE550323 T1 AT E550323T1 AT 05749871 T AT05749871 T AT 05749871T AT 05749871 T AT05749871 T AT 05749871T AT E550323 T1 ATE550323 T1 AT E550323T1
Authority
AT
Austria
Prior art keywords
piperidinyl
intra
lowering agents
prostaglandin analogs
eye pressure
Prior art date
Application number
AT05749871T
Other languages
English (en)
Inventor
David Old
Danny Dinh
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE550323T1 publication Critical patent/ATE550323T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05749871T 2004-06-04 2005-05-16 Piperidinyl-prostaglandinanaloga als den augeninnendruck senkende mittel ATE550323T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57736104P 2004-06-04 2004-06-04
PCT/US2005/017167 WO2005121086A2 (en) 2004-06-04 2005-05-16 Piperidinyl prostaglandin analogs as ocular hypotensive agents

Publications (1)

Publication Number Publication Date
ATE550323T1 true ATE550323T1 (de) 2012-04-15

Family

ID=35431920

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05749871T ATE550323T1 (de) 2004-06-04 2005-05-16 Piperidinyl-prostaglandinanaloga als den augeninnendruck senkende mittel

Country Status (9)

Country Link
US (1) US7435746B2 (de)
EP (1) EP1761495B1 (de)
AT (1) ATE550323T1 (de)
AU (1) AU2005252171A1 (de)
CA (1) CA2569464C (de)
DK (1) DK1761495T3 (de)
ES (1) ES2381377T3 (de)
PL (1) PL1761495T3 (de)
WO (1) WO2005121086A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326716B2 (en) * 2003-06-06 2008-02-05 Allergan, Inc. Treatment of inflammatory bowel disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2296122C2 (ru) * 2001-07-16 2007-03-27 Ф.Хоффманн-Ля Рош Аг Производные 2-пирролидона в качестве простаноидных агонистов и фармацевтическая композиция
WO2003047513A2 (en) * 2001-12-03 2003-06-12 Merck & Co., Inc. Method for treating ocular hypertension
AU2003207900A1 (en) * 2002-03-18 2003-09-29 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
CN1735597A (zh) * 2003-01-10 2006-02-15 霍夫曼-拉罗奇有限公司 作为前列腺素激动剂的2－哌啶酮衍生物
CA2528179C (en) * 2003-06-06 2013-10-22 Allergan, Inc. Piperidinyl prostaglandin e analogs

Also Published As

Publication number Publication date
EP1761495B1 (de) 2012-03-21
WO2005121086A3 (en) 2006-04-27
US20060281713A1 (en) 2006-12-14
CA2569464A1 (en) 2005-12-22
AU2005252171A1 (en) 2005-12-22
EP1761495A2 (de) 2007-03-14
WO2005121086A2 (en) 2005-12-22
PL1761495T3 (pl) 2012-07-31
CA2569464C (en) 2012-10-23
ES2381377T3 (es) 2012-05-25
US7435746B2 (en) 2008-10-14
DK1761495T3 (da) 2012-06-18

Similar Documents

Publication Publication Date Title
EA200702445A1 (ru) Соединения тиазола и способы их применения
EA200600648A1 (ru) Производные пурина, ингибирующие репликацию вич
CY1106634T1 (el) Θεραπευτικα παραγωγα της πιπεραζινης
NO20073357L (no) 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien
EA200600892A1 (ru) Новые хинолиновые производные
ATE517882T1 (de) Chinolinderivate
IS8503A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
EA200870423A1 (ru) Производные триазолпиразинов, применимые в качестве противораковых агентов
BRPI0413876A (pt) tienopiridin-fenilacetamidas e seus derivados úteis como agentes antiangiogênicos
CY1113766T1 (el) Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
EA200602130A1 (ru) Замещенные арилацилтиомочевины и родственные соединения; ингибиторы репликации вирусов
BRPI0413152A (pt) derivados de benzimidazol alquilado por n3 como inibidores de mek
EA200601350A1 (ru) Азотсодержащие гетероциклические производные и их фармацевтические применения
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
EA201391263A1 (ru) Комбинированные терапии гематологических опухолей
EA200501098A1 (ru) Антибактериальные агенты
DK1664016T3 (da) Terapeutiske midler, der er anvendelige til behandling af smerter
EA201391486A1 (ru) Способы и композиции для лечения болезни паркинсона
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
EA200701780A1 (ru) Противоопухолевое средство
EA200601249A1 (ru) Пиперазины, пригодные для лечения боли
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
WO2004066952A3 (en) Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
EA201001470A1 (ru) Производные 5-гидрокси-4-аминометил-l-циклогексил (или циклогептил)-3-алкоксикарбонилиндолов, их фармацевтически приемлемые соли, обладающие противовирусной активностью, и способ их получения